Drugs in R & D

, Volume 9, Issue 3, pp 185–190 | Cite as

Alfimeprase

Adis R&D Profile

Keywords

Acute Ischaemic Stroke Alteplase Central Venous Access Device Thrombolytic Activity Target Product Profile 

References

  1. 1.
    Nuvelo Inc. Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications. Media Release: 26 Jun 2007. Available from URL: http://www.nuvelo.com Google Scholar
  2. 2.
    Nuvelo Inc. Nuvelo to Gain Worldwide Rights to Alfimeprase Through Amgen Licensing Agreement. Media Release: 1 Nov 2004. Available from URL: http://www.nuvelo.com Google Scholar
  3. 3.
    Nuvelo Inc. Nuvelo Reduces Expenses and Realigns Organization To Focus on Programs Expected To Yield Nearest-Term Proof-of-Concept Data. Media Release: 2 Aug 2007. Available from URL: http://www.nuvelo.com Google Scholar
  4. 4.
    Nuvelo Inc. Nuvelo and Bayer HealthCare Enter Comprehensive Collaboration Agreement to Maximize Global Development and Commercialization of Alfimeprase. Media Release: 5 Jan 2006. Available from URL: http://www.nuvelo.com Google Scholar
  5. 5.
    Nuvelo Inc. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development. Media Release: 17 Mar 2008. Available from URL: http://www.nuvelo.com Google Scholar
  6. 6.
    Nuvelo Inc, Bayer HealthCare. Nuvelo and Bayer Healthcare Announce Phase 3 Trials of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion and Catheter Occlusion Did Not Meet Primary Endpoints. Media Release: 12 Dec 2006. Available from URL: http://www.nuvelo.com. Summary in 2 parts (Part A)Google Scholar
  7. 7.
    Nuvelo Inc. Nuvelo Announces Results from Phase 3 NAPA Program in Acute Peripheral Arterial Occlusion. Media Release: 24 Jan 2008. Available from URL: http://www.nuvelo.com. Summary in 2 parts (Part A)Google Scholar
  8. 8.
    Nuvelo Inc. Nuvelo Announces Completion of Patient Enrollment in NAPA-2, First Phase 3 Trial of Alfimeprase in Acute Peripheral Arterial Occlusion. Media Release: 5 Sep 2006. Available from URL: http://www.nuvelo.com Google Scholar
  9. 9.
    Nuvelo Inc. Nuvelo Reports First Quarter 2006 Financial Results and Accomplishments. Media Release: 5 May 2006. Available from URL: http://www.nuvelo.com Google Scholar
  10. 10.
    Nuvelo Inc. Nuvelo and Bayer Healthcare Begin NAPA-3, Second Pivotal Phase 3 Trial of Alfimeprase for Acute Peripheral Arterial Occlusion. Media Release: 10 Apr 2006. Available from URL: http://www.nuvelo.com Google Scholar
  11. 11.
    Novel Arterial Perfusion with Alfimeprase (NAPA) Investigators. Alfimeprase, a novel direct-acting fibrinolytic agent in acute peripheral arterial occlusion: report of a phase 2, multi-center, open-label, dose-defining study. Circulation 114 (Suppl.): 648 (plus poster) abstr. 2777, No. 18, 31 Oct 2006CrossRefGoogle Scholar
  12. 12.
    Nuvelo Inc. Nuvelo Announces the Completion of Its Phase 2 Alfimeprase Trial in Acute Peripheral Arterial Occlusion. Media Release: 28 Jun 2004. Available from URL: http://www.nuvelo.com Google Scholar
  13. 13.
    Nuvelo Inc. Nuvelo Phase 2 Clinical Trial Results Show Potential of Alfimeprase to Treat Acute Peripheral Arterial Occlusion, Also Known as ‘Leg Attack’. Media Release: 30 Sep 2004. Available from URL: http://www.nuvelo.com Google Scholar
  14. 14.
    Nuvelo Inc. Nuvelo Announces Successful Results in Phase I Clinical Trial. Media Release: 27 Mar 2003. Available from URL: http://www.nuvelo.com Google Scholar
  15. 15.
    Nuvelo Inc. Nuvelo Announces Completion of Patient Enrollment in SONOMA-2, First Phase 3 Trial of Alfimeprase in Central Venous Catheter Occlusion. Media Release: 5 Sep 2006. Available from URL: http://www.nuvelo.com Google Scholar
  16. 16.
    Nuvelo Inc, Bayer HealthCare. Nuvelo and Bayer HealthCare Begin SONOMA-3, Second Phase 3 Trial of Alfimeprase in Patients With Central Venous Catheter Occlusion. Media Release: 27 Feb 2006. Available from URL: http://www.nuvelo.com Google Scholar
  17. 17.
    Nuvelo Inc. Nuvelo Reports Third Quarter 2005 Financial Results and Accomplishments. Media Release: 1 Nov 2005. Available from URL: http://www.nuvelo.com Google Scholar
  18. 18.
    Nuvelo Inc. Nuvelo Begins Phase 3 Program Evaluating Alfimeprase in Patients With Central Venous Catheter Occlusion. Media Release: 6 Sep 2005. Available from URL: http://www.nuvelo.com Google Scholar
  19. 19.
    Nuvelo Inc. Nuvelo Announces Design of Phase 3 Alfimeprase Program in Patients With Central Venous Catheter Occlusion. Media Release: 26 May 2005. Available from URL: http://www.nuvelo.com. Summary in 2 parts (Part A)Google Scholar
  20. 20.
    Nuvelo Inc. Nuvelo Provides 2006 Clinical Guidance at JPMorgan Conference. Media Release: 9 Jan 2006. Available from URL: http://www.nuvelo.com Google Scholar
  21. 21.
    Nuvelo Inc. Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion. Media Release: 6 Jul 2006. Available from URL: http://www.nuvelo.com Google Scholar
  22. 22.
    Nuvelo Inc. Nuvelo Reports Successful Completion of Interim Analysis in Phase 2 Trial With Alfimeprase in Catheter Occlusion. Media Release: 8 Jun 2004. Available from URL: http://www.nuvelo.com Google Scholar
  23. 23.
    Nuvelo Inc. Nuvelo Announces Strategy to Accelerate Catheter Occlusion Program. Media Release: 12 Jul 2004. Available from URL: http://www.nuvelo.com Google Scholar
  24. 24.
    Nuvelo Inc. Nuvelo Initiates Phase II Clinical Trial in Catheter Occlusion. Media Release: 5 Jun 2003. Available from URL: http://www.nuvelo.com Google Scholar
  25. 25.
    Nuvelo Inc. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke. Media Release: 12 Dec 2007. Available from URL: http://www.nuvelo.com Google Scholar
  26. 26.
    Moll S, Gabrail N, Buchanan J, et al. Safety and efficacy of alfimeprase in subjects with occluded central venous access devices: the SONOMA-2 study. Blood 110: 552–553 (plus poster) abstr. 1866, No. 11, Part 1, Nov 2007Google Scholar
  27. 27.
    Nuvelo Inc. Nuvelo Announces Publication of Alfimeprase Phase 1 Clinical Trial Results. Media Release: 8 Aug 2005. Available from URL: http://www.nuvelo.com Google Scholar

Copyright information

© Adis Data Information BV 2008

Personalised recommendations